Place des mesures rapportées par les patients (PROMS/PREMS) dans l’évaluation et la valorisation des technologies de santé en France

Autor: Christophe Roussel, Olivier Chassany, Isabelle Durand-Zaleski, Anne Josseran, Lise Alter, Pascal Auquier, Sandrine Bourguignon, Joude Cachoux, Claire Desforges, Judith Fernandez, Anne-Françoise Gaudin, Anne-Françoise Germe, Estelle Haenel, Patrick Olivier, Nicolas Maillard, Nicolas Naïditch, Thao Nguyen, Clarisse Péan, Catherine Rumeau-Pichon, Jean-Patrick Sales, Nathalie Schmidely, Philippe Tuppin, Muriel Vray

Publikováno v: Therapies. 77:89-102

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::d96502ecef714c66485a63946eeb3377
https://doi.org/10.1016/j.therap.2022.01.007

Impact of booster vaccination on the control of COVID-19 Delta wave in the context of waning immunity: application to France in the winter 2021/22

Autor: Paolo Bosetti, Cécile Tran Kiem, Alessio Andronico, Juliette Paireau, Daniel Levy-Bruhl, Lise Alter, Arnaud Fontanet, Simon Cauchemez

Publikováno v: Eurosurveillance
Eurosurveillance, 2022, 27 (1), ⟨10.2807/1560-7917.es.2022.27.1.2101125⟩
Eurosurveillance, European Centre for Disease Prevention and Control, 2022, 27 (1), ⟨10.2807/1560-7917.es.2022.27.1.2101125⟩

Europe has experienced a large COVID-19 wave caused by the Delta variant in winter 2021/22. Using mathematical models applied to Metropolitan France, we find that boosters administered to ≥ 65, ≥ 50 or ≥ 18 year-olds may reduce the hospitalisat

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f97e28b0ce4ed4828d916835ea5d4723
https://hal.sorbonne-universite.fr/hal-03518970/document

Benefits and risks associated with different uses of the COVID-19 vaccine Vaxzevria: a modelling study, France, May to September 2021

Autor: Lise Alter, Daniel Lévy-Bruhl, Cécile Tran Kiem, Pierre-Yves Boëlle, Paolo Bosetti, Simon Cauchemez, Juliette Paireau, Alessio Andronico, Arnaud Fontanet

Publikováno v: Eurosurveillance
Eurosurveillance, 2021, 26 (26), ⟨10.2807/1560-7917.es.2021.26.26.2100533⟩
Eurosurveillance, European Centre for Disease Prevention and Control, 2021, 26 (26), ⟨10.2807/1560-7917.es.2021.26.26.2100533⟩

International audience; Thrombosis with thrombocytopenia (TTS) has been identified as a rare adverse event following COVID-19 vaccination with Vaxzevria. We modelled the benefits and risks of Vaxzevria distribution from May to September 2021 in metro

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::74e4e9787cf304e8c4d1edcc87fd4ec4
https://hal.sorbonne-universite.fr/hal-03278110